May 16, 2017

Bought Allergan on weakness

Doug Kass is a fan of Allergan and continues to like Allergan. He has been adding to his long AGN positions on weakness over the last few weeks. 

He remains committed to Allergan and places this stock in his Long Term Investment bucket. 

The shares were originally put on his Best Ideas List in December 2016 at $194 per share and is currently trading at around $230 per share.